236 related articles for article (PubMed ID: 19640790)
1. Genitourinary rhabdomyosarcoma: which treatment, how much, and when?
Wu HY; Snyder HM; Womer RB
J Pediatr Urol; 2009 Dec; 5(6):501-6. PubMed ID: 19640790
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of rhabdomyosarcoma patients with isolated lung metastases from IRS-IV.
Rodeberg D; Arndt C; Breneman J; Lyden E; Donaldson S; Paidas C; Andrassy R; Meyer W; Wiener E
J Pediatr Surg; 2005 Jan; 40(1):256-62. PubMed ID: 15868594
[TBL] [Abstract][Full Text] [Related]
3. Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.
Harel M; Ferrer FA; Shapiro LH; Makari JH
Urol Oncol; 2016 Feb; 34(2):103-15. PubMed ID: 26519985
[TBL] [Abstract][Full Text] [Related]
4. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
5. [Standards, options and recommendations (SOR) for clinical care of rhabdomyosarcoma (RMS) and other soft tissue sarcoma in children. Federation of the French Cancer Centers. French Society of Pediatric Oncology].
Sommelet D; Pinkerton R; Brunat-Mentigny M; Farsi F; Martel I; Philip T; Ranchere-Vince D; Thiesse P
Bull Cancer; 1998 Dec; 85(12):1015-42. PubMed ID: 9917554
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
7. Pediatric rhabdomyosarcoma in Morocco.
Hessissen L; Kanouni L; Kili A; Nachef MN; El Khorassani M; Benjaafar N; Khattab M; El Gueddari Bel K
Pediatr Blood Cancer; 2010 Jan; 54(1):25-8. PubMed ID: 19746454
[TBL] [Abstract][Full Text] [Related]
8. Pediatric urologic rhabdomyosarcoma.
Stehr M
Curr Opin Urol; 2009 Jul; 19(4):402-6. PubMed ID: 19440152
[TBL] [Abstract][Full Text] [Related]
9. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
10. [Genitourinary rhabdomyosarcoma in childhood].
González Rivero MA; Mulet JF; Martín JC; Illa J; Melo M; Pardo N; Turmo J; Vela E; Badía RM; Cubells J
Cir Pediatr; 1989 Oct; 2(4):186-90. PubMed ID: 2488079
[TBL] [Abstract][Full Text] [Related]
11. Delayed radiotherapy following dose intensive chemotherapy for parameningeal rhabdomyosarcoma (PM-RMS) of childhood.
Douglas JG; Arndt CA; Hawkins DS
Eur J Cancer; 2007 Apr; 43(6):1045-50. PubMed ID: 17368885
[TBL] [Abstract][Full Text] [Related]
12. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC
J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146
[TBL] [Abstract][Full Text] [Related]
13. Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation.
Voûte PA; Vos A; de Kraker J; Behrendt H
Natl Cancer Inst Monogr; 1981 Apr; (56):121-5. PubMed ID: 7300888
[TBL] [Abstract][Full Text] [Related]
14. DNA content and proliferative activity in pediatric genitourinary rhabdomyosarcoma.
San Miguel-Fraile P; Carrillo-Gijón R; Rodríguez-Peralto JL; Ortiz-Rey JA; Alvarez-Alvarez C; de la Fuente-Buceta A
Pediatr Pathol Mol Med; 2003; 22(2):143-52. PubMed ID: 12556294
[TBL] [Abstract][Full Text] [Related]
15. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
[TBL] [Abstract][Full Text] [Related]
16. [The treatment results in children with malignant mesenchymal tumors according to the protocols of the International Society of Pediatric Oncology (SIOP)].
López Pérez J; Melero Moreno C; Vivanco Martínez JL; Torres Valdivieso MJ; Cela de Julián E
An Esp Pediatr; 1996 Jun; 44(6):557-60. PubMed ID: 8849098
[TBL] [Abstract][Full Text] [Related]
17. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
[TBL] [Abstract][Full Text] [Related]
18. Rhabdomyosarcoma: an overview.
Dagher R; Helman L
Oncologist; 1999; 4(1):34-44. PubMed ID: 10337369
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary elaboration of the method of complex treatment of rhabdomyosarcoma].
Bozek J; Czerwiński W; Woźniak W
Probl Med Wieku Rozwoj; 1984; 13():154-63. PubMed ID: 6549411
[TBL] [Abstract][Full Text] [Related]
20. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
